4 Chloro 5 Iodo 7 2 C Methyl Beta D Ribofuranosyl 7h Pyrrolo 2 3 D Pyrimidine

This is the nomenclature of 4-chloro-5-iodine-7- (2-C-methyl - β - D-furanribosyl) -7H-pyrrolido [2,3-d] pyrimidine. To clarify its chemical structure, it should be explained according to the nomenclature of organic chemistry.
"pyrrolido [2,3-d] pyrimidine" is the core parent ring structure of this compound. Pyrrolimidine is a heterocyclic system formed by fusing pyrrole ring with pyrimidine ring. The designation "[2,3-d]" is used to pinpoint the location where the two rings fuse.
"7- (2-C-methyl - β - D-furanosyl) " indicates that there is a glycosyl substituent at position 7 of the parent ring. This glycosyl group is β-D-furanosyl and has a methyl substitution at position 2 of the carbon atom. The β-D-furanosyl group is one of the sugar derivatives and has a specific stereo configuration. The β-configuration is related to the spatial orientation of the substituents on the sugar ring, and D-means that its relative configuration is related to D-glyceraldehyde. 2-C-methyl, that is, methyl, is attached to the carbon atom at the 2nd position of the sugar ring.
"4-chloro-5-iodine" indicates that at the 4th and 5th positions of the parent ring, there are chlorine atoms and iodine atoms as substituents, respectively. Chlorine and iodine are both halogen elements. In this compound, due to their electronegativity and atomic properties, they have significant effects on the physical and chemical properties of the compound.
In summary, the chemical structure of this compound is composed of a pyrrolidine parent ring as the core, with a specific sugar group at the 7th position, and chlorine and iodine atoms at the 4th and 5th positions, respectively. Each part is connected to each other to form its unique chemical structure.

4-Chloro-5-iodine-7- (2-C-methyl - β - D-furan-ribosyl) -7H-pyrrolido [2,3-d] pyrimidine, this is an organic compound. Looking at its structure, it contains chlorine, iodine halide atoms, and furan ribosyl and pyrrolido pyrimidine parent nuclei. Its physical properties are related to many aspects.
The appearance is first mentioned, or it is crystalline, because most of these organic compounds have this state, crystal shape or regular, color or white to yellowish, depending on purity and crystallization conditions.
times and melting points, due to factors such as intermolecular forces, hydrogen bonds, etc., have a specific melting point range. Halogen atoms and complex structures enhance the interaction between molecules, and the melting point may be in a higher range. However, the exact value needs to be determined experimentally and accurately.
Solubility is also key. In view of the fact that the molecule contains polar groups such as furan ribosyl, which may have a certain solubility in polar solvents such as methanol and ethanol; however, the large hydrophobic pyrrolidine parent nucleus and halogen atoms have limited solubility in non-polar solvents such as n-hexane.
Furthermore, the density of the compound may vary depending on the type of atom and the tightness of the structure. Heavier halogen atoms make its density relatively high, but the exact density also needs to be measured experimentally.
As for the stability, the halogen atom and the heterocyclic structure have a great influence. Halogen atoms can participate in reactions such as nucleophilic substitution, and pyrrolidine rings may change under specific conditions, so the stability varies according to the environment, and may be relatively stable in dry, low temperature, and dark places.
In summary, the physical properties of this compound are determined by the structure, which is of crucial significance for its research and application.

4 - chloro - 5 - iodo - 7 - (2 - c - methyl - beta - D - ribofuranosyl) - 7H - pyrrolo [2,3 - d] pyrimidine, which is an organic compound. Its main use is in the field of medicine, which involves the development of antiviral drugs. Due to its unique chemical structure, it can affect the key link of the virus replication process, and then exert the effect of antiviral.
In the past, physicians and pharmacists worked hard to study the harm of viruses and wanted to control them. Then pay attention to this compound and explore the mechanism of its interaction with viruses. After repeated trials, it was found that it can interfere with the synthesis of viral nucleic acid through a specific path, making it difficult for the virus to proliferate and spread, just like draining the bottom and curbing its harm.
In the process of scientific research and exploration, this compound is an important tool for in-depth analysis of the laws of viral life activities. Scholars use its unique properties to investigate the mysteries of the internal operation of the virus, laying a solid foundation for the innovation of antiviral drugs. If you want to break the enemy and understand its reality in advance, this compound will be a weapon for understanding the reality of the virus, helping researchers to go deeper and deeper to find more subtle antiviral strategies.

To prepare 4-chloro-5-iodine-7- (2-C-methyl - β - D-furan-ribosyl) -7H-pyrrolido [2,3-d] pyrimidine, there are many methods, and each has its advantages and disadvantages. It is necessary to choose carefully according to the facts.
First, use furan ribose as the starting material. First, the furan ribose is reacted in a specific way, and its hydroxyl group is shielded with a suitable protective group to prevent it from participating in the subsequent reaction without reason and causing the product to be complicated. Commonly used protective groups include silicon ethers, benzyl groups, etc., which are carefully selected according to the reaction conditions and needs. After the protection is completed, in the presence of suitable solvents and catalysts, the chlorine and iodine-containing pyrimidine derivatives and the protected furan ribose undergo a condensation reaction. This step requires precise regulation of the reaction temperature, time and the proportion of the reactants, because it has a great impact on the yield and purity of the product. After condensation, carefully remove the protective group to obtain the target product. This process should pay attention to the mild conditions for deprotection to avoid damaging the structure of the product.
Second, start with the construction of the pyrimidine ring. First, use small molecules containing appropriate substituents as raw materials to build a pyrimidine ring structure through multi-step reactions, and introduce chlorine and iodine atoms at the same time. Subsequently, the constructed pyrimidine ring is linked to 2-C-methyl - β - D-furan ribose. This connection step may require the help of coupling reagents or specific catalytic systems to achieve efficient connection. Similarly, the control of reaction conditions is the key, and the activity and reaction selectivity of each reactant need to be comprehensively considered.
Third, the idea of biomimetic synthesis can also be adopted. Simulate the relevant synthesis pathways in vivo, and use enzymes or biocatalysts with specific activities to promote the reaction. Such methods usually have the advantages of mild reaction conditions and high selectivity, but the acquisition of enzymes and the construction of reaction systems may be more complex and the cost may be higher.
In conclusion, when synthesizing 4-chloro-5-iodine-7- (2-C-methyl - β - D-furanribosyl) -7H-pyrrolido [2,3-d] pyrimidine, it is necessary to consider the advantages and disadvantages of each synthesis method, raw material availability, cost and target product quality requirements.

4-Chloro-5-iodine-7- (2-C-methyl - β - D-furanribosyl) -7H-pyrrolido [2,3-d] pyrimidine is a complex organic compound. Looking at its market prospects, it can be said that there are both opportunities and challenges.
In the field of pharmaceutical research and development, such heterocyclic compounds containing specific ribosyl groups often have potential biological activities or can become precursor compounds for new drugs. With the in-depth study of the pathogenesis of various diseases, scientists are actively exploring novel therapeutic targets and drug molecules. If this compound is proven to have a significant inhibitory effect on specific diseases, such as viral infections, tumors, etc., its market demand may grow explosively. In recent years, the market for antiviral and anticancer drugs has continued to expand, and many pharmaceutical companies and scientific research institutions have invested a lot of resources in it. If this compound can stand out, it will definitely gain a place in the market.
However, in actual marketing activities, it also faces many obstacles. First, the complexity and cost of the synthesis process cannot be ignored. The preparation of this compound requires multiple steps of reaction, which requires strict reaction conditions, and the cost of raw materials may be expensive, which will lead to high production costs and limit its large-scale production and application. Secondly, the research and development of new drugs requires a long and rigorous clinical trial process. From cell experiments, animal experiments to human clinical trials, any problem in any link may lead to research and development failure, time-consuming and huge investment. Many pharmaceutical companies may be discouraged due to high risks.
Furthermore, the market competition is quite fierce. New compounds continue to emerge in the pharmaceutical field, and there are many potential drugs of the same type. If this compound does not demonstrate unique advantages in terms of activity, safety, and side effects, it may be difficult to gain a foothold in the market. However, if the above problems can be overcome, the synthesis process can be optimized to reduce costs, and its efficacy and safety can be successfully verified through clinical trials, its market prospect is also extremely broad, and it is expected to become an important drug for the treatment of related diseases, bringing good news to patients, and creating huge economic benefits for R & D enterprises.